about
Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy (UPDATE)Botulinum neurotoxins A and E undergo retrograde axonal transport in primary motor neuronsChanges in Cerebellar Activation After Onabotulinumtoxin A Injections for Spasticity After Chronic Stroke: A Pilot Functional Magnetic Resonance Imaging Study.The role of botulinum toxin injections in the management of muscle overactivity of the lower limb.Injection of botulinum toxin into external laryngeal muscles in pediatric laryngeal paralysis.Botulinum toxin type A injections for the management of muscle tightness following total hip arthroplasty: a case series.Assessing the neurophysiological effects of botulinum toxin treatment for adults with focal limb spasticity: a systematic review.Intrinsic properties and functional changes in spastic muscle after application of BTX-A in children with cerebral palsy: systematic review.Clinical outcome of shoulder muscle transfer for shoulder deformities in obstetric brachial plexus palsy: A study of 150 cases.The efficacy of Botulinum Toxin A on improving ease of care in the upper and lower limbs: a systematic review and meta-analysis using the Grades of Recommendation, Assessment, Development and Evaluation approach.Botulinum toxin type A in motor nervous system: unexplained observations and new challenges.Botulinum Neurotoxins: Biology, Pharmacology, and Toxicology.Botulinum toxin: from spasticity reliever to a neuromotor re-learning tool.Botulinum neurotoxin A impairs neurotransmission following retrograde transynaptic transport.The efficacy of serial casting after botulinum toxin type A injection in improving equinovarus deformity in patients with chronic stroke.Effects of botulinum toxin on strength-duration properties.
P2860
Q24240402-47764A2A-F178-4A1C-9414-15B9F9922C6FQ27339199-CE149529-5AD7-4468-A3D1-EE6A5BEA319BQ36235985-217C2D7E-99A0-4779-A389-6553B549E866Q37011519-98AD519E-3F1C-4070-8337-DC64CEFC4CE7Q37260563-4502D755-52CA-40EC-90D9-F80A3933E024Q37346078-022575EB-7C6E-48CF-A95A-BEB0290B9844Q37939194-8E885D66-1B96-4951-8CB9-2D89A34644D7Q38245465-34DC1528-93DA-4BA6-BFB9-27D3F2F0DBABQ38253708-119AF3CC-6964-44DA-A9A1-F230C1A00420Q38263487-FEDDFB79-7C74-4D43-BDF9-64D3DD0AFA02Q38944196-6A2467CB-8A38-4521-A31C-0BF5B961FA81Q39207459-DD092BCB-5E85-47C9-906F-06E2705DD195Q39362059-04E0013F-E4D3-428C-9068-61E3C1AE108DQ42644905-135D15F9-D6E3-4341-96D0-B06597A5BE71Q48261429-CAA3EC7A-2EA4-42F3-949B-E23E2BEB2EE1Q48904000-76D121A0-E877-4387-9EE7-2F71FAA14A68
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Physiological effects of botulinum toxin in spasticity.
@ast
Physiological effects of botulinum toxin in spasticity.
@en
type
label
Physiological effects of botulinum toxin in spasticity.
@ast
Physiological effects of botulinum toxin in spasticity.
@en
prefLabel
Physiological effects of botulinum toxin in spasticity.
@ast
Physiological effects of botulinum toxin in spasticity.
@en
P2860
P356
P1433
P1476
Physiological effects of botulinum toxin in spasticity.
@en
P2093
Jean-Michel Gracies
P2860
P304
P356
10.1002/MDS.20065
P407
P478
19 Suppl 8
P577
2004-03-01T00:00:00Z